Gilbert's syndrome disclosed during the treatment of hematological malignancies

6Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Gilbert's syndrome (GS) is a benign, familial condition characterized by recurrent asymptomatic non-hemolytic low-grade indirect hyper-bilirubinemia. Conditions related to fasting, stress or co-morbidity might reveal the disease in asymptomatic individuals. Seven patients who were treated for a hematological malignancy were identified with reversible indirect hyperbilirubinemia. Liver function tests in all of them, including bilirubin levels were normal before the therapeutic maneuver, which was the delivery of combined chemotherapy in three cases and a bone marrow transplantation in four (three allografts and one autograft). Bilirubin levels returned to normal in all five patients following treatment. GS should not be overlooked in individuals exposed to these treatments who develop hyperbilirubinemia and jaundice. © 2005 Taylor & Francis Ltd.

Cite

CITATION STYLE

APA

Ruiz-Argülles, G. J., Ruiz-Delgado, G. J., Gömez-Rangel, J. D., & Gömez-Almaguer, D. (2005). Gilbert’s syndrome disclosed during the treatment of hematological malignancies. Hematology, 10(1), 59–60. https://doi.org/10.1080/10245330410001727064

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free